<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02366650</url>
  </required_header>
  <id_info>
    <org_study_id>HERO1</org_study_id>
    <nct_id>NCT02366650</nct_id>
  </id_info>
  <brief_title>Help in the Emergency Room to Detect Organ Dysfunction</brief_title>
  <acronym>HERO</acronym>
  <official_title>Help in the Emergency Room to Detect Organ Dysfunction - The HERO Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective, non-interventional clinical study is to assess the clinical
      validity of a number of markers (including Heparin Binding Protein (HBP), Procalcitonin
      (PCT), C-reactive protein (CRP), White cell count (WCC) and lactate) for indicating the
      presence of organ dysfunction, or outcome, of patients with organ dysfunctions following
      emergency department admission or hospitalization. Secondary objectives are to identify novel
      putative biomarkers and to identify risk factors for negative long-term effects of acute
      critical illness The HBP assay is an enzyme-linked immunosorbent assay (ELISA) for the
      quantitative determination of Heparin Binding Protein in human plasma.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>infection-induced organ dysfunction</measure>
    <time_frame>72 hours</time_frame>
    <description>To evaluate the presence or development of infection-induced organ dysfunction within a 72 hour time period from enrolment at the Emergency Department.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the specificity, sensitivity and accuracy of HBP against other biochemical markers</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate the specificity, sensitivity and accuracy in biochemical markers to predict mortality, ICU-care, days in hospital and the persistence of organ dysfunction.</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate and identify risk factors for a negative long-term (5-10 year) outcome.</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Organ dysfunction 24-36 and 72 hours after arriving at the hospital</measure>
    <time_frame>72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Primary diagnosis infection (y/n)</measure>
    <time_frame>72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• number of days on ward and ICU</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• number of days of antibiotics , time to effective antibiotics</measure>
    <time_frame>72 hrs</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Sepsis</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Lund ED</arm_group_label>
    <description>appr 100-200 patients at Lund ED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Helsingborg ED</arm_group_label>
    <description>appr 100-200 patients at Helsingborg ED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vancouver ED</arm_group_label>
    <description>appr 100 patients at St Paul's hospital ED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bern ED</arm_group_label>
    <description>appr 100 patients at Bern ED</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subject enrolment will be based on adult patients presenting to the emergency department at
        the different sites with suspicion of organ dysfunction or identified at the hospital
        wars/units.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        i) ≥18 years of age ii) 1 or more of the following criteria: Saturation&lt;90% without oxygen
        or &lt;93% with oxygen or reported saturation&lt;90%, Respiratory frequency &gt;25/min, Altered
        mental awareness, Heart rate &gt;120/min, Systolic blood pressure &lt;100 mm Hg. iv) informed
        consent.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>John Boyd</name>
      <address>
        <city>Vancouver</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Helsingborg</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas Tverring</last_name>
      <email>jonas@tverring.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lund ED</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Linder</last_name>
      <email>adam.linder@med.lu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bern ED</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Sweden</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>February 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2015</study_first_posted>
  <last_update_submitted>October 19, 2015</last_update_submitted>
  <last_update_submitted_qc>October 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Adam Linder</investigator_full_name>
    <investigator_title>MD,PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

